Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.
1983355 citationsE. J. Corey, C Shih et al.Proceedings of the National Academy of Sciencesprofile →
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
1984235 citationsC Shih, E. J. Corey et al.Journal of Biological Chemistryprofile →
Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
1984222 citationsJean‐Michel Mencia‐Huerta, C Shih et al.Journal of Clinical Investigationprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of C Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Shih more than expected).
This network shows the impact of papers produced by C Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Shih. The network helps show where C Shih may publish in the future.
Co-authorship network of co-authors of C Shih
This figure shows the co-authorship network connecting the top 25 collaborators of C Shih.
A scholar is included among the top collaborators of C Shih based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Shih. C Shih is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Shih, C, et al.. (2015). Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38alpha/MAPKAPK-2 and PK-N3 signaling pathway ; Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38α/MAPKAPK-2 and PK-N3 signaling pathway.2 indexed citations
3.
Álvarez, Enrique, et al.. (2002). Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.. PubMed. 15(3). 185–93.24 indexed citations
Teicher, Beverly A., Krishna Menon, Enrique Álvarez, et al.. (2001). Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.. PubMed. 7(3). 634–40.47 indexed citations
Schultz, Richard M., Vinod F. Patel, John F. Worzalla, & C Shih. (1999). Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514.. PubMed. 19(1A). 437–43.101 indexed citations
Coleman, D. L., et al.. (1998). A sensitive and specific radioimmunoassay for LY309887, a potent inhibitor of glycinamide ribonucleotide formyltransferase.. PubMed. 4(1). 157–63.1 indexed citations
11.
Shih, C, Lynn S. Gossett, Susan B. Gates, et al.. (1997). LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.. PubMed. 57(6). 1116–23.490 indexed citations
12.
Worzalla, John F., et al.. (1996). Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid.. PubMed. 56(10). 2331–5.56 indexed citations
13.
Habeck, Lillian L., Katherine A. Shackelford, Lynn S. Gossett, et al.. (1994). A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors.. PubMed. 54(4). 1021–6.54 indexed citations
Shih, C, et al.. (1984). Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.. Journal of Biological Chemistry. 259(4). 2383–2389.235 indexed citations breakdown →
19.
Mencia‐Huerta, Jean‐Michel, et al.. (1984). Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.. Journal of Clinical Investigation. 74(6). 1922–1933.222 indexed citations breakdown →
20.
Corey, E. J., C Shih, & John R. Cashman. (1983). Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.. Proceedings of the National Academy of Sciences. 80(12). 3581–3584.355 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.